Search Results
OCA Symposium: Dr George Au-Yeung on immunotherapy combinations in high-grade serous ovarian cancer
OCA Symposium: Dale Garsed on immunotherapy
IGNITE Clinical Trial Explained
Dr. O’Malley on Antitumor Activity With Veliparib Combo in Serous Ovarian Cancer
Ovarian Cancer Australia Symposium 2016: Professor David Bowtell on beating the odds.
Ovarian Cancer Australia Symposium 2016: Dr Rachel Delahunty on Traceback.
What Are the Subtypes of Ovarian Cancer?
2017 CRI Immunotherapy Patient Summit - Maureen, ovarian cancer patient
The Evolution of PARP Inhibitors in Ovarian Cancer
PARP Inhibitors: New Insights & Future of Ovarian Cancer Treatment
Neoadjuvant Chemotherapy in High-Grade Serous Carcinoma
Dr. Markman on Immune Targeting in Ovarian Cancer
